A Spinal Cord Stimulator (SCS) or Dorsal Column Stimulator (DCS) is a type of implantable neuromodulation device (sometimes called a "pain pacemaker") that is used to send electrical signals to select areas of the spinal cord (dorsal columns) for the treatment of certain pain conditions. SCS is a consideration for people who have a pain condition that has not responded to more conservative therapy.

The global Spinal Cord Stimulator (SCS) Systems market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Spinal Cord Stimulator (SCS) Systems volume and value at global level, regional level and company level. From a global perspective, this report represents overall Spinal Cord Stimulator (SCS) Systems market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Spinal Cord Stimulator (SCS) Systems in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Spinal Cord Stimulator (SCS) Systems manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Medtronic
Boston Scientific
Abbott (St. Jude Medical)
Nevro
Nuvectra
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Rechargeable
Non-Rechargeable

Segment by Application
Failed Back Surgery Syndrome
Complex Regional Pain Syndrome
Chronic Pain
Other